Aktienbewertung
Konkurrenz
| Unternehmen | Börsenwert | G | R | O | W | T | H |
|---|---|---|---|---|---|---|---|
|
Merck NYSE:MRK |
212,71 Mrd. $ | 7,30 % | 6/6 | 8,64 % | 26,95 % | 16,87 % | DOWN |
|
Bristol-Myers Squibb NYSE:BMY |
98,56 Mrd. $ | 0,21 % | 5/6 | 59,64 % | 10,36 % | 13,57 % | DOWN |
|
Jiangsu Hengrui Medicine SHSE:600276 |
375,56 Mrd. ¥ | 4,10 % | 4/6 | 20,34 % | 23,35 % | 15,25 % | UP |
|
BeiGene NasdaqGS:ONC |
34,58 Mrd. $ | 53,94 % | 5/6 | 0,73 % | 46,00 % | 16,99 % | UP |
|
Akeso SEHK:9926 |
133,83 Mrd. HK$ | 0,00 % | 0/2 | 67,42 % | -310,23 % | -24,39 % | UP |
|
CSPC Pharmaceutical Group SEHK:1093 |
98,67 Mrd. HK$ | 5,40 % | 5/6 | 10,15 % | -12,49 % | 11,36 % | UP |
|
Shanghai Fosun Pharmaceutical (Group) SHSE:600196 |
65,25 Mrd. ¥ | 3,43 % | 4/6 | -3,07 % | 21,89 % | 8,78 % | UP |
|
Shanghai Junshi Biosciences SEHK:1877 |
40,38 Mrd. HK$ | 14,89 % | 3/6 | 48,11 % | -13,29 % | -37,58 % | UP |
|
Shanghai Henlius Biotech SEHK:2696 |
37,80 Mrd. HK$ | 115,18 % | 6/6 | 8,38 % | 16,24 % | -10,21 % | UP |
|
Lepu Medical Technology (Beijing) SZSE:300003 |
28,46 Mrd. ¥ | -1,94 % | 0/6 | 75,85 % | -24,99 % | -9,91 % | UP |
|
China Resources Double-Crane Pharmaceutical SHSE:600062 |
20,06 Mrd. ¥ | 6,61 % | 4/6 | 2,58 % | 1,69 % | 28,01 % | UP |
